Related Experiment Videos
Protection from rotavirus reinfection: 2-year prospective study
D I Bernstein1, D S Sander, V E Smith
1Division of Clinical Virology, James N. Gamble Institute of Medical Research, Cincinnati, Ohio 45219.
The Journal of Infectious Diseases
|August 1, 1991
Summary
Natural rotavirus infection provides significant protection against reinfection in infants. Both symptomatic and asymptomatic primary infections offer comparable immunity, lasting at least two years.
Area of Science:
- Virology
- Immunology
- Pediatrics
Background:
- Rotavirus is a leading cause of severe diarrheal disease in infants globally.
- Understanding natural immunity is crucial for evaluating rotavirus vaccine efficacy.
- Previous infections can confer protection against subsequent rotavirus disease.
Purpose of the Study:
- To assess the protective immunity conferred by natural rotavirus infection in infants.
- To determine the duration of protection against homologous serotype reinfection.
- To compare protection from symptomatic versus asymptomatic primary infections.
Main Methods:
- Prospective follow-up of 163 infants in a rotavirus vaccine trial for two years.
- Monitoring for symptomatic and asymptomatic rotavirus reinfections.
- Analysis of protection based on prior infection status and serotype.
Main Results:
- Infants with prior rotavirus infection had significantly fewer symptomatic and any reinfections compared to uninfected infants.
- Asymptomatic primary infection provided protection comparable to symptomatic primary infection.
- Protection against homotypic serotype 1 reinfection persisted for at least two years.
Conclusions:
- Natural rotavirus infection induces robust and durable protection against homologous reinfection.
- Both symptomatic and asymptomatic primary infections contribute to protective immunity.
- Findings support the role of natural immunity in rotavirus disease prevention.